
504PAVID200 neutralizes TGF-beta1 and -beta3, the principal immunosuppressive TGF-beta isoforms overexpressed by tumours, and sensitizes tumours to immune checkpoint inhibitors
Gruosso, T, O’Connor, M, Denis, J -F, Figueredo, R, Koropatnick, J, Tremblay, G, Tikhomirov, I AVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz244.066
Date:
October, 2019
Fichier:
PDF, 75 KB
2019